Capstone Therapeutics to Host Conference Call Discussing First Quarter 2009 Operating Results
May 06, 2009 18:09 ET
|
Capstone Therapeutics
TEMPE, Ariz., May 6, 2009 (GLOBE NEWSWIRE) -- Capstone Therapeutics (Nasdaq:CAPS), trade name of OrthoLogic Corp. (the "Company") will host a conference call and webcast presenting first quarter 2009...
Capstone Therapeutics Announces Publication of Second Data Group (Elevated Cholesterol) From Chrysalin(r) (TP508) Study Demonstrating Significant Benefit in a Pre-Clinical Model of Acute Heart Disease
April 22, 2009 06:00 ET
|
Capstone Therapeutics
TEMPE, Ariz., April 22, 2009 (GLOBE NEWSWIRE) -- Capstone Therapeutics (Nasdaq:CAPS) today announced publication of results from the second data group of a pre-clinical study demonstrating that...
Capstone Therapeutics Announces Initiation of Dosing for AZX100 Phase 2 Pilot Study in Keloid Scarring
April 03, 2009 14:42 ET
|
Capstone Therapeutics
TEMPE, Ariz., April 3, 2009 (GLOBE NEWSWIRE) -- Capstone Therapeutics (Nasdaq:CAPS) announced today the initiation of dosing for its AZX100 Phase 2 pilot clinical trial in keloid scarring.
The Phase...
Capstone Therapeutics Announces Publication of First Data Group From Chrysalin(r) (TP508) Study Demonstrating Significant Benefit in a Pre-Clinical Model of Acute Heart Disease
March 05, 2009 11:00 ET
|
Capstone Therapeutics
TEMPE, Ariz., March 5, 2009 (GLOBE NEWSWIRE) -- Capstone Therapeutics (Nasdaq:CAPS) today announced publication of results from the first data group of a pre-clinical study demonstrating that...
Capstone Therapeutics Announces Initiation of Dosing for AZX100 Phase 2 Clinical Trial in Dermal Scarring; Management to Host Teleconference and Webcast Today
February 10, 2009 08:00 ET
|
Capstone Therapeutics
TEMPE, Ariz., Feb. 10, 2009 (GLOBE NEWSWIRE) -- Capstone Therapeutics (Nasdaq:CAPS) announced today the initiation of dosing for its AZX100 Phase 2 clinical trial in dermal scarring.
The clinical...
Capstone Therapeutics to Host Investor Update Teleconference and Webcast February 10, 2009
February 05, 2009 08:00 ET
|
Capstone Therapeutics
TEMPE, Ariz, Feb. 5, 2009 (GLOBE NEWSWIRE) -- Capstone Therapeutics (Nasdaq:CAPS) will host a teleconference and webcast to discuss operating plans on Tuesday, February 10, 2009 at 4:30pm EST/ 3:30pm...
Capstone Therapeutics Announces Chrysalin(r) (TP508, Rusalatide Acetate) Scientific Abstracts to be Presented At the American Society for Cell Biology 48th Annual Meeting; Studies Characterize Integrin Interaction and Biologic Activity
December 15, 2008 12:00 ET
|
Capstone Therapeutics
TEMPE, Ariz., Dec. 15, 2008 (GLOBE NEWSWIRE) -- Capstone Therapeutics (Nasdaq:CAPS) announced today the publication of several abstracts characterizing the science of its novel thrombin peptide...
Capstone Therapeutics Announces Positive Safety Results in Primary Endpoint From Second AZX100 Phase 1 Clinical Trial in Dermal Scarring; Pharmacologic Signal Shown in Secondary Endpoints
December 10, 2008 15:00 ET
|
Capstone Therapeutics
TEMPE, Ariz., Dec. 10, 2008 (GLOBE NEWSWIRE) -- Capstone Therapeutics (Nasdaq:CAPS) announced today positive safety results were obtained in the second of two planned Phase 1 human clinical trials of...
Capstone Therapeutics Announces Third Quarter 2008 Financial Results
November 06, 2008 07:00 ET
|
Capstone Therapeutics
TEMPE, Ariz., Nov. 6, 2008 (GLOBE NEWSWIRE) -- Capstone Therapeutics (Nasdaq:CAPS), trade name of OrthoLogic Corp. (the "Company"), today announced financial results for the third quarter 2008.
The...
Capstone Therapeutics Receives NASDAQ Notice Temporarily Suspending Minimum Bid Price Rule
October 22, 2008 19:00 ET
|
Capstone Therapeutics
TEMPE, Ariz., Oct. 22, 2008 (GLOBE NEWSWIRE) -- Capstone Therapeutics (Nasdaq:CAPS), trade name of OrthoLogic Corp. ("the Company"), received on August 11, 2008 a letter dated August 8, 2008 from The...